Search

The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.

… Thursday, June 13, 2024 On June 13, 2024, a targeted drug called  repotrectinib (Augtyro TM ) received accelerated approval from the US Food and Drug Administration (FDA) for treating cancers caused by gene changes called  NTRK fusions. The clinical trial that resulted in the approval was led globally

A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center.

… Thursday, May 19, 2011 A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center. The findings, which

… Job Title Graduate Research Assistant

Memorial Sloan Kettering medical oncologist Maria Rubinstein specializes in caring for people with gynecologic cancers, including uterine (endometrial) cancer, cervical cancer, and ovarian cancer.

… Gynecologic Medical Oncologist Job Title Assistant Attending Physician I am a medical oncologist and clinical researcher with a primary focus on caring for people with gynecologic cancers. These include ovarian , uterine (endometrial) , and cervical cancers . As part of a specialized multidisciplinary

La médica oncóloga del Memorial Sloan Kettering Maria Rubinstein se especializa en la atención de personas con cánceres ginecológicos, incluido el cáncer de útero (endometrio), el cáncer cervical y el cáncer de ovario.

… Gynecologic Oncologist Job Title Adjunta asistente Soy médica oncóloga e investigadora clínica y me dedico principalmente al cuidado de personas con cánceres ginecológicos. Estos incluyen cánceres de ovario , de útero (endometrial) y cervical . Como parte de un equipo multidisciplinario especializado

Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Recognizing the significant unmet needs in this cohort, we recently published a review of the latest treatment options.

… Wednesday, October 14, 2020 Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Further treatments may provide symptom relief but are rarely definitive for disease management in this cohort. Recognizing the significant unmet needs

… Job Title Research Associate - currently: Research Fellow, Neurological Clinical Research Institute at MGH/ Harvard Neuroinflammation impacts most neurodegenerative disorders, including Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s Disease) - a progressive neurodegenerative disease characterized by

… Kelly KK, Allen PA, Coit DO, Brennan MF, Strong VE. Internal hernia after gastrectomy with Roux-Y reconstruction for cancer. Surgery, 2013, in press. La Femina J, Vinuela EF, Schattner MA, Gerdes H, Strong VE. Esophagojejunal reconstruction after total gastrectomy for gastric cancer using a transorally

Learn how the Center for Molecular Imaging and Bioengineering at MSK unites molecular imaging and bioengineering to transform our understanding of cancer and its detection and treatment.

… About the Center The mission of the Center for Molecular Imaging and Bioengineering (CMIB) is to integrate novel molecular imaging methods and state-of-the-art bioengineering tools to revolutionize the way Memorial Sloan Kettering Cancer Center (MSK) approaches cancer research. In uniting these transformational

… Job Title Research Assistant